Researchers at the Multi-disciplinary Association for Psychedelic Studies (MAPS) working in partnership with the University of Arizona College of Medicine are fighting for the right to conduct a three month investigation into the clinical affects of treating ex-military personnel suffering from Post Traumatic Stress Disorder (PTSD) with marijuana.
Currently the proposed study has been halted while the National Institute on Drug Abuse and Public Health Service decides whether or not to sell marijuana to the project.
The outcome of this struggle by medical researchers is critical for the service men and women who are suffering from symptoms of PTSD that have not diminished or ceased under current medical practices.
The university researchers are proposing a triple-blind and placebo-controlled experiment in which the optimum dosage and its exact effect on each symptom of this disabling condition will be examined.
Currently the Drug Enforcement Administration (DEA) has not accepted urges to consider reclassifying marijuana, and the U.S. Food and Drug Administration (FDA) has officially opposed the use of marijuana as medicine .
Marijuana is currently used as medication in countries and particular states of America that have more relaxed laws over its consumption as a naturally occurring medicine to aid pain relief and overcome illness.